NCT07915752Not yet recruiting
A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
Exercise is known to prevent nearly one in three cases of hypertension and slow its progression in young adults, but we do not know which specific exercise types are most effective. The main objective of this study is to determine which exercise prescription (ExRx) intervention component(s) alone or in combination most effectively lower systolic BP in young adults with stage I hypertension, identify the vascular mechanisms underlying these changes, and guide the development of optimized exercise-based prescription packages for effective hypertension control in this population.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 264 (estimated)
- First submitted
- 29 Oct 2026
- Start date
- 1 May 2027
- Primary completion date
- Jul 2030
- Lead sponsor
- Northwestern University
- Diseases
- High blood pressure
- NCT number
- NCT07915752
What you commit to
- Study type: Interventional
- Planned participants: 264
- From 1 May 2027 to the primary completion date, Jul 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of a GLP-1 receptor agonist within the past year Weight change of more than 15 lbs in the prior 3 months Pregnant or planning to become pregnant within 6 months Active cancer and/or currently receiving cancer treatment History of type 1 or type 2 diabetes History of chronic kidney disease History of chronic obstructive pulmonary disease History of cardiovascular disease or coronary heart disease Absolute contraindication to exercise (e.g., severe neurological, psychological, or orthopedic condition)
Who the study is looking for
- Age 18-44 years Northwestern University patient with untreated Stage I hypertension (blood pressure 130-139/80-89 mmHg) documented on at least 2 outpatient encounters in the prior year No current antihypertensive medication use Estimated 10-year cardiovascular disease risk below 7.5% by the PREVENT risk calculator Body mass index 18.5-39.9 kg/m² Average home blood pressure of 130-139/80-89 mmHg during a 7-day home monitoring period Fewer than 150 minutes per week of moderate-to-vigorous physical activity measured by accelerometer Exercise readiness confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+), with medical clearance if indicated English fluency Reliable internet access on a computer, smartphone, or tablet, with videoconference capability (e.g., Zoom)
Age in the registry: 18 years to 44 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.